Obesity Clinical Trial
Official title:
Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods
The changing food environment, with increasingly abundant ultra-processed food (UPF) options, may directly contribute to rising rates of obesity, though it is unknown which ingredients in UPF elevate their reinforcing nature in a way that may lead to overconsumption. The proposed study is the first to systematically examine differences in the rewarding characteristics of and physiological and metabolic responses to UPFs that are high in fat, refined carbohydrates (like sugar), or both. Understanding the biobehavioral underpinnings that enhance the reinforcing potential of ingredients in UPF (e.g., fat vs. refined carbohydrates) can inform novel intervention targets for the treatment of overeating and obesity.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | March 31, 2027 |
Est. primary completion date | March 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - 18 to 65 years old - BMI = 30 kg/m2 - Endorse liking the test snack foods at a 6 on a 1-10 scale - Live in the greater Philadelphia area and are willing/able to participate in six in-person assessments - Can access and are willing/able to use a smartphone - Able to give consent Exclusion Criteria: - Unable to fluently speak, write, and read English - BMI below 30 kg/m2 - Self-report dietary allergies or aversions to the test snack foods - Current diagnosis of type 1 or 2 diabetes (HbA1c > 6.5; will be confirmed by blood test at baseline) or self-reported diagnosis of hypertension - Self-report a cardiovascular event (e.g., stroke, myocardial infarction) in the last 12 months - Self-report current use of medications that may influence the metabolic responses of interest or inhibit appetite (e.g., metformin, liraglutide) - Self-report a loss of = 5% of their body weight in the last 6 months, as this may influence their food choices - Self-report severe symptoms of mood (Beck Depression Inventory score = 29), anxiety, and any severity of thought disorders - Self-report severe binge eating disorder or full criteria bulimia nervosa - Self-report active substance-use disorders - Self-report current, active suicidal ideation, and/or a suicide attempt in the past year (will be referred to psychiatric treatment facilities in the greater Philadelphia area) - Self-report a history of bariatric surgery - Self-report current involvement in weight loss treatment or self-directed weight loss attempt - Women who are nursing, pregnant, or planning to become pregnant in the next 3 months - Does not have access or are not willing to use a smartphone |
Country | Name | City | State |
---|---|---|---|
United States | Drexel University | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Drexel University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Individual risk factors for enhanced ultra-processed food reward | Characteristics known to increase one's reward responsiveness to substances like alcohol will be assessed by behavioral tasks and evaluated as predictors of ultra-processed food reward (delay discounting task to assess impulsivity; Stroop task to assess cognitive functioning; relative reinforcing value task to assess reward value of various foods). | Tasks administered at baseline assessment (prior to any food consumption appointments) or follow-up assessment (at least one week or up to 2 months after the last food consumption appointment) | |
Primary | Subjective reward responses to food intake (in lab) | Indicators of subjective reward (craving, palatability, hedonic hunger, and mood) will be assessed by participants' self-reports before, during, and after consumption of the test snack at each of the four food consumption appointments. Each facet of subjective reward will be assessed by 100-point visual analog scales ranging from 0-100. | 10 minutes before intake of test snack, during, and 30-, 60-, 90-, and 120 minutes after intake of the test snack. | |
Primary | Subjective reward responses to food intake (EMA) | Indicators of subjective reward (craving, palatability, hedonic hunger, and mood) will be assessed by participants' self-reports in EMA surveys. Each facet of subjective reward will be assessed by 100-point visual analog scales ranging from 0-100. | EMA surveys administered over 5 days following each food consumption assessment (20 total days of EMA data) | |
Primary | Ad libitum consumption | Total number of calories consumed from the test snack food during a 15-minute eating period. Calories will calculated by measuring bowls containing the test snacks before and after participant consumption on a digital scale accurate to 0.01 grams. The difference in grams will be converted into the calories that the participant ate. | 2 hours after test snack intake at each food consumption assessment. | |
Primary | Daily calorie intake (EMA) | Calorie intake will be derived from participants' self-reported food consumption in EMA surveys. | EMA surveys administered over 5 days following each food consumption assessment (20 total days of EMA data) | |
Primary | Consumption of UPFs and MPFs (EMA) | Trained study staff will calculate the percentage of participants' daily calories from the four food categories (UPF+FRC, UPF+F, UPF+RC, MPF) based on participants' self-reported food consumption in EMA surveys. | EMA surveys administered over 5 days following each food consumption assessment (20 total days of EMA data) | |
Secondary | Changes in heart rate in response to food intake | Manually measured by counting the radial pulse for 15 seconds (timed using a digital stopwatch). | 10 minutes before intake of test snack, during, and 30-, 60-, 90-, and 120 minutes after intake of the test snack. | |
Secondary | Salivation responses to food intake | Participants will spit into a plastic cup for 1 minute and the weight of their saliva will be measured in grams using a digital food scale accurate to 0.01 grams. | 10 minutes before intake of test snack, during, and 30-, 60-, 90-, and 120 minutes after intake of the test snack. | |
Secondary | Magnitude of metabolic responses to food intake | Serial blood draws will be conducted before, during, and after test snack consumption. Samples will be assayed for glucose, insulin, ghrelin, and leptin levels. | 10 minutes before intake of test snack, during, and 30-, 60-, 90-, and 120 minutes after intake of the test snack. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |